L. Reynoso Jamie's most recent trade in Clover Health Investments Corp - Ordinary Shares - Class A was a trade of 19,789 Class A Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 03 Jul 2025 | 19,789 | 3,308,539 | - | 2.6 | 51,056 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 03 Jul 2025 | 8,706 | 3,299,833 | - | 2.6 | 22,287 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Sale of securities on an exchange or to another person at price $ 2.85 per share. | 03 Jul 2025 | 2,012 | 3,297,821 | - | 2.8 | 5,734 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 217,523 | 3,413,924 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.79 per share. | 30 Jun 2025 | 85,596 | 3,328,328 | - | 2.8 | 238,813 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Sale of securities on an exchange or to another person at price $ 2.86 per share. | 17 Jun 2025 | 20,450 | 3,196,401 | - | 2.9 | 58,487 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 14 Jun 2025 | 12,567 | 3,225,542 | - | 2.9 | 36,319 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 14 Jun 2025 | 8,691 | 3,216,851 | - | 2.9 | 25,117 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 30 Apr 2025 | 25,659 | 3,238,109 | - | 3.4 | 87,241 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 03 Apr 2025 | 6,366 | 3,263,768 | - | 3.5 | 22,345 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.66 per share. | 14 Mar 2025 | 9,188 | 3,276,488 | - | 3.7 | 33,628 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.66 per share. | 14 Mar 2025 | 6,354 | 3,270,134 | - | 3.7 | 23,256 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.39 per share. | 31 Jan 2025 | 21,578 | 3,285,676 | - | 4.4 | 94,727 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.29 per share. | 03 Jan 2025 | 8,149 | 3,324,396 | - | 3.3 | 26,810 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.11 per share. | 14 Dec 2024 | 12,567 | 3,341,236 | - | 3.1 | 39,083 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.11 per share. | 14 Dec 2024 | 8,691 | 3,332,545 | - | 3.1 | 27,029 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.12 per share. | 31 Oct 2024 | 118,050 | 3,353,803 | - | 4.1 | 486,366 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 726,114 | 3,471,853 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 03 Oct 2024 | 8,706 | 2,745,739 | - | 4 | 34,824 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 259,000 | 2,877,620 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 101,917 | 2,775,703 | - | 3.0 | 304,732 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 12,567 | 2,763,136 | - | 3.0 | 37,575 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 8,691 | 2,754,445 | - | 3.0 | 25,986 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 03 Jul 2024 | 5,388 | 2,618,620 | - | 1.3 | 6,735 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 217,522 | 2,676,975 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.23 per share. | 30 Jun 2024 | 52,967 | 2,624,008 | - | 1.2 | 65,149 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 14 Jun 2024 | 7,776 | 2,459,453 | - | 1.1 | 8,476 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 14 Jun 2024 | 5,378 | 2,454,075 | - | 1.1 | 5,862 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 03 Apr 2024 | 5,387 | 2,467,229 | - | 0.8 | 4,094 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 15 Mar 2024 | 5,378 | 2,472,616 | - | 0.8 | 4,302 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.73 per share. | 14 Mar 2024 | 7,777 | 2,477,994 | - | 0.7 | 5,677 | Class A Common Stock |
| Clover Health Investments ... | Reynoso Jamie L. | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.95 per share. | 07 Jan 2024 | 16,369 | 2,485,771 | - | 1.0 | 15,551 | Class A Common Stock |
| Clover Health Investments ... | L. Reynoso Jamie | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 03 Jan 2024 | 26,240 | 2,502,140 | - | 0.9 | 24,141 | Class A Common Stock |
| Clover Health Investments ... | L. Jamie Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.95 per share. | 01 Jan 2024 | 1,559 | 2,528,380 | - | 0.9 | 1,481 | Class A Common Stock |
| Clover Health Investments ... | L. Jamie Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 15 Dec 2023 | 8,691 | 2,529,825 | - | 1.0 | 8,604 | Class A Common Stock |
| Clover Health Investments ... | Reynoso L. Jamie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 14 Dec 2023 | 12,567 | 2,538,516 | - | 1 | 12,567 | Class A Common Stock |
| Clover Health Investments ... | L. Reynoso Jamie | CEO, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2023 | 652,566 | 2,033,451 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 14 Jun 2023 | 7,776 | 1,380,885 | - | 0.9 | 7,309 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 353,982 | 1,454,877 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 353,356 | 1,100,895 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 510,948 | 747,539 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 31 Jan 2022 | 1,281 | 235,310 | - | 2.6 | 3,305 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 07 Jan 2022 | 31,455 | 1,388,661 | - | 0.9 | 29,253 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 07 Jan 2022 | 16,369 | 1,421,397 | - | 1.0 | 16,533 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.16 per share. | 07 Jan 2022 | 15,830 | 1,437,766 | - | 3.2 | 50,023 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | CEO of Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.33 per share. | 07 Jan 2022 | 1,281 | 1,420,116 | - | 1.3 | 1,704 | Class A Common Stock |
| Clover Health Investments ... | Jamie L. Reynoso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 220,820 | 220,820 | - | 0 | Class A Common Stock |